Sonia Ares-Gómez, Narmeen Mallah, Jacobo Pardo-Seco, Alberto Malvar-Pintos, Olaia Pérez-Martínez, María-Teresa Otero-Barrós, Nuria Súarez-Gaiche, Maria-Isolina Santiago-Pérez, Juan-Manuel González-Pérez, Luis-Ricardo López-Pérez, Benigno Rosón, Rosa-María Alvárez-Gil, Olga-María Ces-Ozores, Victoria Nartallo-Penas, Susana Mirás-Carballal, Carmen Rodríguez-Tenreiro, Irene Rivero-Calle, Antonio Salas, Carmen Durán-Parrondo, Federico Martinón-Torres
BACKGROUND: The morbidity burden of respiratory syncytial virus (RSV) in infants extends beyond hospitalization. Defining the RSV burden before implementing prophylaxis programs is essential for evaluating any potential impact on short- to mid-term morbidity and the utilization of primary healthcare (PHC) and emergency services (ES). We established this reference data using a population-based cohort approach. METHODS: Infants hospitalized for RSV from January 2016 to March 2023 were matched with non-hospitalized ones based on birthdate and sex...
May 2024: Pediatric Allergy and Immunology